bf/NASDAQ:IKNA_icon.jpeg

NASDAQ:IKNA

Ikena Oncology

  • Stock

1.22

−3.94%

−0.21

USD last updated 13/08 01:59:42

Last Close

1.43

25/07 22:02

Market Cap

78.18M

Beta: 0.75

Volume Today

123K

Avg: 63.66K

PE Ratio

−0.98

PFCF: −0.87

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small mole...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52019-12-302020-12-312022-03-172023-05-152024-08-082025-08-06

    Revenue (Estimate*)

    5M10M15M20M2019-12-302020-12-312022-03-172023-05-152024-08-082025-08-06

    *Estimate based on analyst consensus